FDA Inspection 1012214 — University of Pittsburgh Cancer Institute Cancer Service
The FDA completed an inspection of University of Pittsburgh Cancer Institute Cancer Service on April 17, 2017 in Erie, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 17, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Erie, PA (United States)